Sequelae of chlamydial PID include infertility an ectopic pregnancy that occur as a consequence of tubal damage and obstruction. The disease process associated with chlamydial infections is thought to be largely immunologically mediated. A unique persistent form of chlamydiae has been characterized in several cell culture systems and development of persistence has been documented to be driven by immune-regulated cytokines. To effectively study persistence in vivo, an animal model that sufficiently reflects upper genital tract disease is needed. Ideally, this model should exhibit qualities that allow for precise immunologic characterization and be well defined genetically. With these considerations in mind, the murine model for chlamydial PID will be adapted to study the problem of chlamydial persistence. The hypothesis to be tested is that chlamydial persistence is a determining factor in the development of oviduct disease.
The aims of the proposed wok are to adapt and further develop the murine model of PID, to document the presence of persistent chlamydiae in uterine and/or oviduct tissue, to study the effects of immune reactivity on persistence, and to compare mechanisms of persistence induction between human and murine chlamydial host cells in culture. Results of this study will provide information important in understanding the pathogenesis of chlamydial upper genital tract disease, could contribute to improved diagnosis of silent chlamydial PID in women, and may ultimately be useful to rational vaccine development for this important human pathogen.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI019782-10A2
Application #
2061026
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1982-08-01
Project End
1999-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
10
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Grayston, J Thomas; Belland, Robert J; Byrne, Gerald I et al. (2015) Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested. Pathog Dis 73:1-9
Peters, Jan; Byrne, Gerald I (2015) Chlamydia trachomatis growth depends on eukaryotic cholesterol esterification and is affected by Acyl-CoA:cholesterol acyltransferase inhibition. Pathog Dis 73:ftv028
Patil, Renukadevi; Szabó, Erzsébet; Fells, James I et al. (2015) Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist. Chem Biol 22:206-16
Bonner, Carol A; Byrne, Gerald I; Jensen, Roy A (2014) Chlamydia exploit the mammalian tryptophan-depletion defense strategy as a counter-defensive cue to trigger a survival state of persistence. Front Cell Infect Microbiol 4:17
Bavoil, Patrik M; Byrne, Gerald I (2014) Analysis of CPAF mutants: new functions, new questions (the ins and outs of a chlamydial protease). Pathog Dis 71:287-91
Jonsson, Colleen B; Cole, Kelly Stefano; Roy, Chad J et al. (2013) Challenges and Practices in Building and Implementing Biosafety and Biosecurity Programs to Enable Basic and Translational Research with Select Agents. J Bioterror Biodef Suppl 3:12634
Abdelsamed, Hossam; Peters, Jan; Byrne, Gerald I (2013) Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism. Future Microbiol 8:1129-1146
Miyairi, Isao; Ziebarth, Jesse; Laxton, Jonathan D et al. (2012) Host genetics and Chlamydia disease: prediction and validation of disease severity mechanisms. PLoS One 7:e33781
Ziebarth, Jesse D; Bhattacharya, Anindya; Chen, Anlong et al. (2012) PolymiRTS Database 2.0: linking polymorphisms in microRNA target sites with human diseases and complex traits. Nucleic Acids Res 40:D216-21
Peters, Jan; Onguri, Vijaya; Nishimoto, Satoru K et al. (2012) The Chlamydia trachomatis CT149 protein exhibits esterase activity in vitro and catalyzes cholesteryl ester hydrolysis when expressed in HeLa cells. Microbes Infect 14:1196-204

Showing the most recent 10 out of 43 publications